Literature DB >> 7831775

Identification and characterization of the orf virus type I topoisomerase.

N Klemperer1, D J Lyttle, D Tauzin, P Traktman, A J Robinson.   

Abstract

Vaccinia virus (VV) and Shope fibroma virus (SFV), representatives of the orthopox and leporipox genera, respectively, encode type I DNA topoisomerases. Here we report that the 957-nt F4R open reading frame of orf virus (OV), a representative of the parapox genus, is predicted to encode a 318-aa protein with extensive homology to these enzymes. The deduced amino acid sequence of F4R has 54.7 and 50.6% identity with the VV and SFV enzymes, respectively. One hundred forty amino acids are predicted to be conserved in all three proteins. The F4R protein was expressed in Escherichia coli under the control of an inducible T7 promoter, partially purified, and shown to be a bona fide type I topoisomerase. Like the VV enzyme, the OV enzyme relaxed negatively supercoiled DNA in the absence of divalent cations or ATP and formed a transient covalent intermediate with cleaved DNA that could be visualized by SDS-PAGE. Both the noncovalent and covalent protein/DNA complexes could be detected in an electrophoretic mobility shift assay. The initial PCR used to prepare expression constructs yielded a mutant allele of the OV topoisomerase with a G-A transition at nt 677 that was predicted to replace a highly conserved Tyr residue with a Cys. This allele directed the expression of an enzyme which retained noncovalent DNA binding activity but was severely impaired in DNA cleavage and relaxation. Incubation of pUC19 DNA with the wild-type OV or VV enzyme yielded an indistinguishable set of DNA cleavage fragments, although the relative abundance of the fragments differed for the two enzymes. Using a duplex oligonucleotide substrate containing the consensus site for the VV enzyme, we demonstrated that the OV enzyme also cleaved efficiently immediately downstream of the sequence CCCTT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831775     DOI: 10.1016/s0042-6822(95)80035-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Mutational analysis of vaccinia virus topoisomerase identifies residues involved in DNA binding.

Authors:  J Sekiguchi; S Shuman
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

2.  Characterization of mimivirus DNA topoisomerase IB suggests horizontal gene transfer between eukaryal viruses and bacteria.

Authors:  Delphine Benarroch; Jean-Michel Claverie; Didier Raoult; Stewart Shuman
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  The vaccinia virus I1 protein is essential for the assembly of mature virions.

Authors:  N Klemperer; J Ward; E Evans; P Traktman
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Molluscum contagiosum virus topoisomerase: purification, activities, and response to inhibitors.

Authors:  Y Hwang; B Wang; F D Bushman
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.

Authors:  Flavio Da Fonseca; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

6.  The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro.

Authors:  K Liu; B Lemon; P Traktman
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

7.  A functional type I topoisomerase from Pseudomonas aeruginosa.

Authors:  Teesta Jain; Benjamin J Roper; Anne Grove
Journal:  BMC Mol Biol       Date:  2009-03-24       Impact factor: 2.946

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.